Gain Therapeutics (GANX)
(Delayed Data from NSDQ)
$1.12 USD
-0.08 (-6.67%)
Updated Jul 8, 2024 04:00 PM ET
After-Market: $1.12 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.31 | 0.00% |
Earnings Summary
For their last quarter, Gain Therapeutics (GANX) reported earnings of -$0.22 per share, beating the Zacks Consensus Estimate of $-0.30 per share. This reflects a positive earnings surprise of 26.67%. Look out for GANX's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.31 per share, reflecting a year-over-year increase of 50%.
Earnings History
Price & Consensus
Zacks News for GANX
Adherex Technologies Inc. (FENC) Lags Q1 Earnings Estimates
GANX: What are Zacks experts saying now?
Zacks Private Portfolio Services